Price
Financials
Standalone, Rs crore| Jun 2009 | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 30.87 | 73.91 | 117.69 | 132.00 | 150.57 | 20.79 | 201.44 | 114.03 | 171.12 |
| Expenses | 25.39 | 67.70 | 96.90 | 114.99 | 130.00 | 22.11 | 191.42 | 108.43 | 165.90 |
| Operating Profit | 5.48 | 6.21 | 20.79 | 17.01 | 20.57 | -1.32 | 10.02 | 5.60 | 5.22 |
| OPM % | 17.75% | 8.40% | 17.67% | 12.89% | 13.66% | -6.35% | 4.97% | 4.91% | 3.05% |
| Other Income | 0.00 | -45.41 | 0.00 | -0.14 | 0.00 | 7.83 | 0.00 | 4.37 | 4.92 |
| Interest | 1.16 | 9.93 | 11.74 | 8.31 | 12.67 | 10.29 | 8.69 | 8.68 | 8.85 |
| Depreciation | 0.20 | 5.42 | 5.10 | 5.15 | 5.15 | 5.04 | 1.25 | 1.26 | 1.26 |
| Profit before tax | 4.12 | -54.55 | 3.95 | 3.41 | 2.75 | -8.82 | 0.08 | 0.03 | 0.03 |
| Tax % | 30.10% | -30.03% | 18.23% | 48.97% | 32.36% | -30.27% | 37.50% | 33.33% | 33.33% |
| Net Profit | 2.88 | -38.17 | 3.24 | 1.74 | 1.86 | -6.15 | 0.06 | 0.02 | 0.02 |
| EPS in Rs | -27.49 | 2.33 | 1.25 | 1.34 | -1.94 | 0.01 | 0.00 | 0.00 |
| Mar 2007 15m | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 22 | 90 | 162 | 320 | 480 | 521 | 421 | 507 |
| Expenses | 0 | 17 | 79 | 132 | 250 | 375 | 415 | 364 | 488 |
| Operating Profit | 0 | 5 | 11 | 29 | 71 | 105 | 106 | 57 | 20 |
| OPM % | 22% | 12% | 18% | 22% | 22% | 20% | 14% | 3.9% | |
| Other Income | 0 | 0 | 0 | 1 | 0 | 2 | -40 | 8 | 17 |
| Interest | 0 | 1 | 3 | 6 | 14 | 29 | 43 | 43 | 37 |
| Depreciation | 0 | 0 | 1 | 1 | 3 | 16 | 20 | 20 | 9 |
| Profit before tax | 0 | 4 | 8 | 23 | 55 | 63 | 3 | 1 | -9 |
| Tax % | 37% | 35% | 34% | 34% | 35% | 80% | 48% | ||
| Net Profit | 0 | 2 | 5 | 15 | 36 | 41 | 1 | 1 | -6 |
| EPS in Rs | 29.55 | 0.40 | 0.21 | -1.93 | |||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 25% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 36% | 10% | 7% | ||
| Compounded Profit Growth | % | -33% | -74% | -144% | ||
| Stock Price CAGR | % | % | % | % | ||
| Return on Equity | % | 13% | 9% | 0% |
| Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Sep 2014 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 2 | 5 | 6 | 8 | 14 | 14 | 32 | 53 |
| Reserves | -0 | 2 | 7 | 44 | 127 | 336 | 296 | 376 | 475 |
| Borrowings | 1 | 12 | 38 | 60 | 139 | 299 | 550 | 495 | 366 |
| Other Liabilities | 0 | 11 | 11 | 25 | 22 | 70 | 186 | 360 | 164 |
| Total Liabilities | 1 | 28 | 61 | 135 | 295 | 718 | 1,045 | 1,263 | 1,058 |
| Fixed Assets | 0 | 11 | 13 | 47 | 70 | 214 | 208 | 188 | 186 |
| CWIP | 1 | 0 | 0 | 4 | 47 | 144 | 164 | 179 | 343 |
| Investments | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 213 | 213 |
| Other Assets | 0 | 17 | 47 | 84 | 178 | 359 | 670 | 683 | 316 |
| Total Assets | 1 | 28 | 61 | 135 | 295 | 718 | 1,045 | 1,263 | 1,058 |
| Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 0 | -2 | -22 | 1 | -46 | -46 | 40 | 135 |
| Cash from Investing Activity | -1 | -11 | -3 | -39 | -68 | -256 | -36 | -226 |
| Cash from Financing Activity | 1 | 13 | 26 | 38 | 114 | 305 | 205 | -120 |
| Net Cash Flow | 0 | 0 | 1 | 0 | -0 | 3 | 208 | -211 |
| Free Cash Flow | -1 | -13 | -25 | -38 | -114 | -303 | 5 | 119 |
| CFO/OP | -50% | -196% | 10% | -62% | -24% | 39% | 237% |
| Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 205 | 125 | 98 | 103 | 153 | 191 | 317 | |
| Inventory Days | 63 | 76 | 107 | 129 | 142 | 157 | 194 | |
| Days Payable | 0 | 0 | 46 | -9 | 41 | 150 | 326 | |
| Cash Conversion Cycle | 269 | 201 | 158 | 242 | 253 | 198 | 185 | |
| Working Capital Days | 110 | 150 | 135 | 183 | 228 | 202 | 293 | |
| ROCE % | 52% | 31% | 36% | 36% | 20% | 12% | 5% |
Fundamentals
Market Cap₹ Cr.
Current Price₹ 6.40
Book Value₹ 50.2
ROCE5.03 %
ROE0.19 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)7%
Compounded Profit Growth (TTM)-144%
Standalone figures.
Valuation
Market capRs 9 Cr
Enterprise valueRs 303 Cr
Price to book0.03x
Price to sales0.02x
EV / EBITDA6.44x
EV / EBIT8.83x
EV / sales0.62x
Earnings yield-47.36%
P/E, 3-year average18.47x
P/B, 3-year average2.17x
P/E, 5-year average18.47x
P/B, 5-year average2.17x
Profitability
Operating margin (excl. other income)21.97%
Operating margin (incl. other income)22.46%
EBITDA margin9.67%
Pre-tax margin-1.22%
Net profit margin-0.86%
Net margin, latest quarter0.02%
ROE16.95%
ROCE19.99%
ROA8.10%
ROE, 3-year average34.88%
ROCE, 3-year average30.65%
ROA, 3-year average13.43%
ROE, 5-year average54.90%
ROCE, 5-year average35.02%
ROA, 5-year average13.64%
ROIC (approx.)3.47%
Tax rate34.91%
Other income / net worth0.67%
Growth
Sales growth (latest year)49.87%
Profit growth (latest year)13.94%
Sales CAGR, 3 years74.63%
Profit CAGR, 3 years100.64%
Sales growth QoQ-43.39%
Profit growth QoQ-66.67%
Sales growth YoY (latest quarter)-13.61%
Profit growth YoY (latest quarter)-98.85%
Per share
EPS (TTM)Rs -3.03
EPS (latest year)Rs 29.54
EPS (latest quarter)Rs 0.01
EPS, 3-year averageRs 34.39
EPS, 5-year averageRs 25.01
Book value per shareRs 251.84
Sales per shareRs 350.49
Cash flow per shareRs -32.99
Free cash flow per shareRs 85.67
Efficiency
Asset turnover0.67x
Fixed asset turnover2.24x
Inventory turnover2.64x
Inventory days138 days
Debtor days153 days
Debtors turnover2.39x
Creditor days326 days
Cash conversion cycle185 days
Working capital days293 days
Leverage
Total debtRs 299 Cr
Cash and bankRs 4 Cr
Net debtRs 294 Cr
Debt to equity0.85x
Net debt / EBITDA6.26x
Interest coverage0.85x
Owners' fund to total sources48.72%
Debt to assets41.59%
Cash flow
Cash from Operating Activity (latest year)Rs -46 Cr
Cash from Investing Activity (latest year)Rs -256 Cr
Cash from Financing Activity (latest year)Rs 305 Cr
Net Cash Flow (latest year)Rs 3 Cr
Free cash flow (latest year)Rs 119 Cr
FCFE (approx.: FCF + change in debt)Rs 279 Cr
Cash from ops / profit, 5 years0.89x
Statement figures
Net sales (TTM)Rs 487 Cr
Net sales (latest year)Rs 480 Cr
Sales (latest quarter)Rs 114 Cr
Operating profit excl. other income (latest year)Rs 105 Cr
Operating profit (latest quarter)Rs 6 Cr
Other income (TTM)Rs 2 Cr
EBITDA (TTM)Rs 47 Cr
PBDT (TTM)Rs 7 Cr
Profit before tax (TTM)Rs -6 Cr
Tax (latest year)Rs 22 Cr
Net profit (TTM)Rs -4 Cr
Net profit (latest year)Rs 41 Cr
Net profit (latest quarter)Rs 0 Cr
Depreciation (TTM)Rs 13 Cr
Depreciation (latest quarter)Rs 1 Cr
Interest (TTM)Rs 40 Cr
Cost of goods sold (latest year)Rs 363 Cr
Total expenditure (latest year)Rs 375 Cr
Total income (latest year)Rs 482 Cr
Share capitalRs 14 Cr
ReservesRs 336 Cr
Shareholders' fundsRs 350 Cr
Total assetsRs 718 Cr
Net blockRs 214 Cr
Capital work in progressRs 144 Cr
InvestmentsRs 1 Cr
ReceivablesRs 201 Cr
InventoryRs 138 Cr
Other liabilitiesRs 70 Cr
Shares outstanding (crore)1.39
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | DRDATSONS | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -21.5% | -2.8% | -18.7 pts |
| 1 month | -59.4% | -6.8% | -52.6 pts |
| 3 months | -5.9% | -7.6% | +1.7 pts |
| 6 months | -52.2% | +0.4% | -52.6 pts |
| 1 year | -69.5% | -9.9% | -59.5 pts |
| 2 years | -92.2% | -13.6% | -78.6 pts |
| 3 years | -98.7% | +14.2% | -112.9 pts |
Red flags
F-score 3 of 8| explain | Weak cash conversion Cash from operations was -99% of net profit over the last 3 years |
| explain | High accruals Profit exceeded operating cash by 12% of total assets in 2014 |
| explain | Receivables outrunning sales Receivables grew 122% vs sales +50% in 2014 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Dec 2014Sales ₹171 Cr +13.6% vs Dec 2013.
Net profit ₹0 Cr -98.9%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2014-09-22 | Annual General Meeting | |
| 2013-09-20 | Annual General Meeting/Dividend Re 0.10/- Per Share | |
| 2012-08-31 | Annual General Meeting And Dividend Rs.2/- Per Share | |
| 2011-09-21 | Annual General Meeting |
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Dr.Datsons Labs Ltd?
Dr.Datsons Labs Ltd (DRDATSONS) has a market capitalisation of Rs Cr. at the 2015-05-21 close.
What were Dr.Datsons Labs Ltd's latest quarterly results?
In the Dec 2014 quarter, Dr.Datsons Labs Ltd sales was Rs 171 Cr (+13.6% vs Dec 2013) and net profit was Rs 0 Cr.